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ABSTRACT 
 CHARACTERIZATION OF THE NORSPERMIDINE/SPERMIDINE TRANSPORT PROTEIN, POTD1, 
IN VIBRIO CHOLERAE 
Alexandria Colett Rutkovsky, B.S., Appalachian State University 
M.S., Appalachian State University 
Chairperson: Dr. Ece Karatan 
 Biofilm formation plays a large role in antibiotic resistance among bacteria 
and therefore proves to be an imperative avenue of research for future therapies. To 
combat biofilm formation, we must have a thorough understanding of all of the 
proteins and molecules that have an effect on biofilm formation. One such protein, 
PotD1, has been previously shown to negatively regulate biofilm formation in Vibrio 
cholerae, an aquatic bacterium which is also an intestinal pathogen. This protein was 
identified as the periplasmic ligand binding protein of the putative ATP-binding 
cassette transporter PotABCD1 and was shown to be responsible for uptake of the 
polyamine spermidine into V. cholerae. The purpose of this study was to 
biochemically characterize the PotD1 protein further. Overall, this work focused to 
understand the binding properties of the PotD1 protein to its ligands and ultimately its 
effect on biofilm formation in V. cholerae through genetic characterization of the 
ligand binding cleft and the ability of PotD1 to interact with various polyamines 
which have the potential to alter biofilm levels in this bacterium. The results 
demonstrated that in addition to spermidine, PotD1 is also responsible for the import 
of a closely related polyamine, norspermidine. Since no norspermidine transporters 
v 
have been identified to date in any organism, the PotABCD1 transporter is the first 
example of a norspermidine transporter. Ligand competition assays showed PotD1 
has a higher binding affinity for spermidine rather than norspermidine. In addition, 
this work showed that the amino acids W252 and D254, hypothesized to be within the 
PotD1 ligand binding cleft, play a large role in spermidine transport, and the amino 
acids E168 and W32 play a less important role. The importance of these same amino 
acids in norspermidine transport are currently unknown, but experiments to determine 
this are underway. Lastly, mutations in the amino acids that diminished spermidine 
import only had a partial effect on biofilm formation, suggesting that spermidine 
uptake and biofilm formation are only partially correlated. Thus, this work also 
demonstrates the ability of PotD1 to alter biofilm formation by both its ability to 
uptake spermidine but also through another yet unidentified mechanism.  
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INTRODUCTION 
Vibrio cholerae is an intestinal pathogen that thrives in aquatic environments by 
forming biofilms which allow the bacterium to survive otherwise harmful conditions. A 
biofilm is a surface aggregation of microorganisms in a complex, self-produced matrix. 
Biofilms are thought to aid the infectivity of V. cholerae, as well as other microbes, by 
providing protection from the host’s natural defense mechanisms, thereby increasing the 
survival rates of bacteria (1, 2). The biofilm matrix is composed of sugars, proteins, and 
DNA, and encases the microorganisms, allowing an unparalleled form of protection from 
chemical and physical stresses (3, 4, 5). Following ingestion, V. cholerae is thought to 
colonize the small intestine by means of chemotaxis (6). Biofilm formation is important in 
aiding colonization of the host intestine by offering protection from the harsh environmental 
conditions encountered at the gastric acid barrier before entering the small intestine of the 
human host (1, 7). In addition, the physiological state of V. cholerae, while present in a 
biofilm and after exiting a biofilm, has been shown to contribute to infectivity (8, 9, 10). The 
biofilm phenotype of V. cholerae can be regulated by various environmental signals through 
the stringent control of complex regulatory systems that ensure the proper phenotype in the 
right environment (11). This work focuses on understanding how small cationic molecules, 
polyamines, are acquired and utilized by V. cholerae to influence biofilm formation.  
Polyamines play a crucial role in optimal cell performance by regulating a variety of 
cellular processes such as regulation of transcription and translation, virulence, stress 
tolerance, and biofilms (12, 13, 14, 15, 16, 17, 18). Their ability to work in conjunction with 
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the regulatory machinery of the cell allows polyamines to act as inhibitors or promoters for a 
variety of regulatory processes by influencing specific proteins, mRNA, or DNA (19, 20, 21, 
22, 23). Almost all cell types possess polyamine synthesis and transport systems to adjust the 
levels of various polyamines such as cadaverine, norspermidine, putrescine, and spermidine 
in the cell. In V. cholerae, polyamine synthesis and transport systems have been shown to 
play an especially large role in biofilm formation (24, 12). Previous results have confirmed a 
relationship between a decrease in biofilm formation with the presence of the polyamine 
spermidine. Similar experiments have also suggested that an increase in biofilm formation 
correlates with an increase in cellular and extracellular norspermidine levels. This is 
especially interesting considering norspermidine and spermidine differ by only one 
methylene group (Figure 1).  
 
 
Figure 1. Polyamines affecting biofilm formation in V. cholerae. Spermidine and 
norspermidine differ by one methylene group.  
 
 
The characteristics of polyamine transport vary in different prokaryotes. In V. cholerae, there 
is thought to be a PotABCD1 spermidine uptake system coded for by a gene cluster 
consisting of potA, potB, potC, potD2, and potD1 genes, respectively (Figure 2), which 
belong to the ATP binding (ABC) cassette transporter family. ABC transporters are diverse 
and plentiful among many species. They are characterized by a certain design which 
incorporates at least two transmembrane domains (TMDs) and two nucleotide binding 
domains (NBDs). ABC transporters can function as excretion mechanisms in both eukaryotic 
and prokaryotic systems, but their ability to act as importers are generally exclusive to 
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prokaryotic organisms and require high affinity binding proteins, like the PotD1 protein in 
the PotABCD2D1 system, to deliver the appropriate ligand to the rest of the transporter (25).  
 
 
 
Figure 2. The PotABCD2D1 operon in V. cholerae. This operon codes for the 
PotABCD2D1 transporter.  
 
The PotABCD2D1 system (Figure 3) is thought to operate similar to the well-characterized 
PotABCD transport system in Escherichia coli, which is responsible for importing both 
spermidine and putrescine in to the cell. This system consists of PotA (an ATPase), PotB and 
PotC (channel forming proteins), and PotD (a substrate binding protein) (26, 27, 28). A 
closer analysis, using bioinformatics, of the pot gene cluster in V. cholerae suggested the role 
of each protein in the PotABCD2D1 operon coincided with the confirmed role within the E. 
coli system, albeit the V. cholerae system is hypothesized to have two substrate binding 
proteins as indicated by analysis of the operon using bioinformatics. In E. coli, all of the Pot 
proteins that are part of the transporter are essential for spermidine uptake (29) but in V. 
cholerae the PotD2 protein is not necessary for spermidine uptake (12). Little is known about 
polyamine uptake mechanisms in V. cholerae; therefore, a closer look at this system is 
warranted. Polyamine transport has been shown to affect other physiological responses of the 
cell. For example, potD gene expression in Streptococcus pneumonia has been shown to 
increase during infection and stressful environmental conditions implying that polyamines 
play a role in bacterial pathogenesis (16, 33). Deletion of the potD1 gene in V. cholerae 
resulted in a loss of spermidine in the cell as well as an increase in biofilm formation. As V. 
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cholerae synthesizes only negligible amounts of spermidine under these conditions (24), this 
result suggested that PotD1 is responsible for the uptake of spermidine into the cell (12).  
 
Figure 3. Hypothesized cellular locations of the spermidine ABC transport system. This 
system is encoded by the PotABCD2D1 operon in V. cholerae. SPD is the common 
polyamine spermidine.  
 
Ubiquitous ABC transporters represent a diverse and often essential protein complex 
for cell survival. Substrate binding proteins, within an ABC transporter system, bind their 
substrates with affinities around 0.01 to 100 uM, and many can bind multiple ligands (30, 31, 
32). Orthologs of the PotD1 protein are present among a diverse range of prokaryotic and 
archaeal species, illustrating the potential of similar function across many organisms (Figure 
4), suggesting its importance in cellular functions as well as ancestral evolutionary presence. 
 
 
Periplasm 
Cytoplasm 
  5 
 
 
Figure 4. Phylogenetic tree depicting PotD1 proteins from various prokaryotic species. 
The tree is based upon the maximum parsimony method, Protpars, and drawn using PhyFi. 
ClustalW was used for multiple sequence alignment.  
 
Because ABC transporters have a large impact on bacterial physiology, a greater 
understanding into mechanisms and abilities of ABC transporters is imperative. 
Understanding the mechanisms behind substrate specificity and binding interaction can prove 
useful in influencing protein function or in understanding protein interactions with 
therapeutic drugs. ABC transporters used for import can be especially good targets for drug 
development since they are generally unique to prokaryotes and are easily accessible due to 
their location in the periplasm of gram negative species or on the cell surface in gram 
positive species (34).  
The purpose of this work was to more thoroughly characterize the binding properties 
of PotD1 to its ligands and ultimately its effect on biofilm formation in V. cholerae. This was 
done through genetic characterization of the ligand binding cleft and the protein’s ability to 
interact with various polyamines which alter biofilm levels in this bacterium. Because 
spermidine and norspermidine differ by only one methylene group, I hypothesized that 
PotD1 may also interact with norspermidine. Therefore, the specific objectives of this 
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research included, i) to determine if PotD1 is able to bind norspermidine, ii) to compare 
binding affinities of spermidine and norspermidine to PotD1, iii) to determine the amino acid 
residues involved in the transport of spermidine by PotD1, and iv) to understand how biofilm 
formation is affected by increase or decrease in uptake activity of the PotD1 protein.  
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MATERIALS AND METHODS 
 
Bacterial strains, plasmids, media and reagents  
     The bacterial strains, plasmids, and primers used throughout this study are listed in Table 
1, Table 2, and Table 3, respectively. Primer synthesis and DNA sequencing were done by 
Eurofins MWG Operon (Huntsville, AL) and Cornell University (Ithaca, NY), respectively. 
All cell growth/cultures were done in Luria-Bertani broth (LB) (1% Tryptone, 0.5% Yeast 
Extract, 85 mM NaCl) unless otherwise stated. The polyamines were purchased from Sigma 
(St.Louis, MO). The restriction enzymes, XhoI, SpeI, EcoRI, NcoI, XmnI, and Phusion and 
OneTaq polymerases were purchased from New England Biolabs (Beverly, MA). Chemicals 
were purchased from Sigma-Aldrich (St Louis, MI), Fisher Scientific (Fairlawn, NJ), or 
Amresco (Solon, OH) unless otherwise stated.  
 
Deletion of the nspC gene 
     To ensure that V. cholerae is not able to synthesize norspermidine, the carboxy-
norspermidine synthesis gene (nspC) was deleted using double homologous recombination. 
The kanamycin aceytltransferase gene was amplified from pKD4 plasmid using the PA207 
forward primer and PA208 reverse primer. A 371 base pair fragment upstream of the nspC 
gene was amplified using the primers P328 and P329. Similarly, a 468 base pair fragment 
downstream of the nspC gene was amplified using the P330 and P331 primers. The primers 
were designed such that the reverse primer, used for the amplification of the upstream nspC 
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fragment, contained complementary regions to PA207, and the forward primer, used for the 
amplification of the downstream fragment, contained complementary regions to PA208. The 
three PCR products were then spliced together by stitching by overlap extension PCR. After 
adding adenines, this product was cloned into a pCR2.1-TOPO vector following the 
manufacturer’s instructions (Invitrogen, Carlsbad, CA), and the sequence was verified. This 
insert was then excised using XhoI and SpeI, and ligated into the pWM91 plasmid linearized 
with the same enzymes,39 electroporated into electrocompetant SM10λpir E. coli using a 
BIO-RAD MicroPulser (Hercules, CA) at 1.8 kV, and verified using colony PCR. Single 
colonies were resuspended in 100 µl of water, heated at 95° C for 5 minutes, and used in 
colony PCR to screen colonies positive for the insert (2 µL of template DNA, 5 µL 5X 
OneTaq Standard Reaction Buffer, 200 µM dNTPs, 0.2 µM of each primer, and 0.125 µL 
OneTaq DNA polymerase in a 25 µL reaction). Cycling conditions were as follows: an initial 
denaturation at 94° C for 5 minutes, 30 cycles of 94° C for 30 seconds, 60° C for 30 seconds, 
68° C for 60 seconds, and a final extension at 68° C for 5 minutes. This strain was used for 
exchange with wild-type V. cholerae. Fresh overnight plates for the recipient V. cholerae and 
donor E. coli containing the plasmid pWM91::∆npsC (hereafter referred to as pAR17) were 
streaked on LB  plates containing streptomycin (100 µg/mL) and ampicillin (100 µg/mL), 
respectively, and incubated overnight at 37° C. The next day, the donor pAR17 was mixed 
with recipient PW357 on LB agar plates and incubated at 37° C overnight. In the morning, 
half of the growth was streaked onto LB agar plates containing streptomycin (100 µg/mL) 
and ampicillin (50 µg/mL) agar for isolation and incubated at 37° C overnight. Four single 
colony isolates were streaked on LB agar containing kanamycin (30 µg/mL) and incubated at 
37° C overnight. The next day, multiple colonies were picked and then streaked for isolation 
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on sucrose plates (10% Sucrose, 1% tryptone, 1.5% agar, 0.5% yeast) containing kanamycin 
(30 µg/mL), and streptomyocin (100 µg/mL). Colonies were also patched on LB agar 
containing ampicillin (50 µg/mL) and kanamycin (30 µg/mL) to ensure no growth and 
confirm successful homologous recombination.  
 
Extraction, benzoylation, and detection of polyamines  
      To determine the identity and the levels of polyamines in V. cholerae, polyamines were 
extracted and analyzed as previously described (40, 12, 13). Briefly, all strains were grown at 
27° C to mid-log phase, pelleted, washed with 1X Phosphate-buffered saline (137 mM NaCl, 
2.7 mM KCl, 10 mM Na2HPO4, and 2 mM KH2PO4, pH 7.4), and resuspended in water at 10 
µL per mg wet cell weight. Cells were then lysed using sonication, and debris was removed 
by centrifugation. The cellular protein was precipitated by a 50% Trichloroacetic acid 
solution (TCA) and centrifuged, leaving the supernatant containing the polyamines. This 
supernatant was removed and benzoylated. The benzoylation procedure as described 
previously (40, 12, 13) required extraction by 1 mL of chloroform twice. The sample was 
then evaporated to dryness, and dissolved in 100 µl mobile phase used for HPLC (60/40 ratio 
methanol and water). Along with the benzoylation of the samples, a standard mix containing 
0.1 mM of each polyamine was prepared each time. HPLC utilized a Waters 1525 Binary 
Pump with a 2487 Dual Wavelength Absorbance Detector  set at 254 nm and a Phenomenex 
Sphereclone 5u ODS column (5 µm, 250 X 4.6 mm) that was fitted with a 4.0 X 3.0 mm 
guard cartridge (Phenomenex, Torrance, CA). The runs were performed using a gradient of 
45-60% methanol in water for 30 minutes with a 10 minute isocratic equilibration of 45% 
methanol in water. Per each run, 40 µl of each sample were injected into the column. To 
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understand if there is competition between norspermidine and spermidine uptake through the 
PotD1 protein, polyamines were added to the media in varying concentrations and cell 
extracts were analyzed as described previously. 
 
Construction of the potD1 gene variants using site-directed mutagenesis  
     To further characterize the PotD1 protein, site-directed mutagenesis was used to alter the 
putative ligand binding site. The primers were designed to generate five different mutations 
in the PotD1 protein, namely, W32L, W252L, E168A, D254N, and D254A. Phusion 
polymerase was used to amplify the potd1 gene in two fragments: the upstream piece was 
amplified using a forward primer that annealed at the beginning of the potd1 gene sequence 
and a reverse mutagenic primer, and a forward mutagenic primer and a reverse primer were 
used for the downstream piece.  The mutagenic primers were complementary which allowed 
splicing together of the pieces using overlap extension PCR. The PCR products were 
separated on a 1% agarose gel and purified using the GE Healthcare Illustra GFX PCR DNA 
and Gel Band Purification Kit (Buckinghamshire, UK). The reverse primer, PA144, encoded 
a V5 epitope tag which allowed incorporation of this antigenic tag into each mutant. Pieces 
were spliced together by overlap extension PCR in a reaction volume of 50 µL with 0.5 µM 
of each primer (PA138 and PA144), 200 µM dNTPs, 10 µL of 5X Phusion HF Buffer, 0.5 
µL Phusion Polymerase, and 10 µL of each PCR product. Cycling parameters were as 
follows: an initial denaturation at 98° C for 30 seconds, 30 cycles of denaturation at 98° C for 
10 seconds, annealing at 60° C for 30 seconds, extension at 72° C for 30 seconds, and a final 
extension at 72° C for 5 minutes. The correct size product was excised from the gel, purified, 
and adenines were added to the blunt ended PCR products using OneTaq polymerase by 
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incubation at 72° C for 10 minutes. The mutated genes were cloned into a pCR2.1-TOPO 
vector (Invitrogen, Carlsbad, CA) and electroporated into electrocompetant DH5α cells using 
a BIO-RAD MicroPulser (Hercules, CA) at 1.8 kV. The transformed cells were incubated in 
SOC medium at 37° C for 1 hour at 200 rpm, and then plated on LB-ampicillin (100 ug/mL) 
with 40 µl of X-gal (20 mg/mL in dimethylformamide). Blue-white screening was used for 
selection of white or light blue colonies, indicative of plasmids carrying the insert. Colony 
PCR, as described previously, was used to confirm the presence of the insert. Colonies 
positive for the insert were grown overnight, plasmids were purified using the Promega 
Wizard Plus SV Minipreps DNA Purification System (Madison, WI) and sequenced to 
confirm the presence of the mutations. The inserts were excised from this plasmid using 
EcoRI and NcoI, ligated into a V. cholerae compatible pACYC184 plasmid linearized with 
the same enzymes, and transformed into DH5α cells. These colonies were screened again for 
the insert using colony PCR as described above; colonies positive for the insert were grown 
overnight, plasmids were purified and transformed into a V. cholerae potD1 mutant and a 
∆potD1∆nspC double mutant.  
 
Western Blotting to confirm the presence of mutant PotD1 proteins 
     Cells were grown overnight in LB broth, pelleted, resuspended in water, and lysed using 
Novagen BugBuster reagent following the manufacturer’s instructions (Darmstadt, 
Germany). Samples were loaded on a denaturing gel with a 12% acrylamide resolving gel 
and 5% stacking gel and run at 250 V for 1 hour. The gel and blotting paper were 
equilibrated in 1X Transfer Buffer containing 50 mM TRIS, 40 mM Glycine, and 1.5 mM 
SDS. A PVDF membrane was quickly exposed to methanol and then incubated in 1X 
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transfer buffer. The gel was transferred to the membrane using a BIO-RAD TransBlot 
(Hercules, CA) for 15 minutes at 15 V. The membrane was blocked overnight with 3% skim 
milk in 1X PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 2 mM KH2PO4, pH 
7.4) at 4° C, and incubated with the V5 antibody conjugated to HRP (AbD Serotec, Raleigh, 
NC), as a 1:1,000 dilution in a 3% skim milk in PBS, for 1 hour with the membrane at room 
temperature. The membrane was then washed three times in PBS with 0.05% Tween 20 and 
visualized calorimetrically using 1-Step TMB-Blotting HRP membrane substrate (Thermo 
Scientific, Rockford, IL). Alternatively, the antibody dilution was adjusted and the 
membrane was incubated with SuperSignal West Pico or Femto Chemiluminescent Substrate 
(Thermo Scientific) for 5 minutes. The membrane was exposed to X-ray film (Bioexpress, 
Kaysville, UT) and developed using a Konica Minolta SRX-101A developer (Konica 
Minolta Medical & Graphic, Inc., China). 
 
Sequence Analysis  
     The sequence of the PotD1 protein (VchoM_00690.1) of V. cholerae O139 was obtained 
from the V. cholerae sequence database maintained at the Broad Institute (Cambridge, MA). 
A protein Blast search was performed on the NCBI database, using the PotD1 sequence, with 
default parameters, to find homologs of this protein in the database. Using multiple sequence 
alignment (MSA), the PotD1 protein was aligned with the E. coli PotD protein. Briefly, the 
sequences were retrieved using the fasta format and were saved in a text program with a fasta 
extension. This file was used for MSA on the ClustalW alignment website 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). The alignment files were saved in phylip 
format. 
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Maximum parsimony to determine phylogeny  
     A maximum parsimony phylogenetic tree was generated using phylip. The ClustalW file 
with phylip extension was loaded into the protpars server, which can be found at the Mobyle 
@ Pasteur website (http://mobyle.pasteur.fr/cgi-bin/portal.py#forms::protpars). The outgroup 
species was adjusted to an archaea species. The propars tree file was then saved and uploaded 
into the Phyfi tree drawing program (http://cgi-www.daimi.au.dk/cgi-chili/phyfi/go).   
 
Modeling of the PotD1 and PotD2 protein  
     SWISS-MODEL was used to predict protein structure using homology to crystal structures 
in the Protein Data Bank (http://www.rcsb.org/pdb/home/home.do). The automated protein 
structure depiction tool was used. The PotD1 protein sequence was uploaded and a 
characterized homologous protein structure was used as the template to configure the 
hypothesized structure. The results were analyzed via the SWISS MODEL server once 
complete, and the pdb file was downloaded for further manipulation. The MOLSOFT ICM 
Browser was used to view the pdb files, give secondary structure prediction, and manipulate 
the structure. 
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Biofilm assays  
     Biofilm assays as previously described (41) were performed in triplicate with all mutants 
multiple times. Briefly, strains were inoculated from overnight cultures and grown at 27° C 
for 24-48 hours, planktonic cells were harvested, and glass beads were used to collect the 
biofilm. A microplate reader (Bio-Rad, Hercules, CA) using a 655 nm filter was used to 
quantify planktonic and biofilm cell density.  
 
pMAL-p5X fusion constructs for protein expression  
     The pMAL Protein Fusion and Purification System (New England Biolabs, Ipswich, MA) 
was used to construct the recombinant PotD1 protein. Briefly, the potD1 gene was amplified, 
using primers PA193 and PA194 with Phusion polymerase, without its signal sequence as 
predicted by SignalP 4.0 (http://www.cbs.dtu.dk/services/SignalP/). An NcoI restriction site 
was engineered into PA194 for cloning into the pMAL-p5X vector in frame with a gene 
encoding the maltose binding protein. The potD1 gene was restricted using NcoI and  leaving 
a blunt end on the 3’ end of the PCR product, purified using the GE Healthcare illustra PCR 
and DNA Purification Kit, ligated into the pMAL-p5X vector linearized using XmnI (a blunt 
end cutter) and NcoI, and transformed into NEB Express E. coli (NEB). The presence of the 
insert was confirmed using colony PCR and plasmids from colonies containing the positive 
clones were isolated and sequenced to confirm no errors were present in the sequence.  
 
Purification of MBP-PotD1 fusion protein  
     The pMAL manual for extracting the periplasm was followed with minor changes. One 
liter of M9 minimal media (0.6 % Na2HPO4, 0.3 %  KH2PO4, 0.05 % NaCl, 0.1 % NH4Cl, 
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0.2 % glucose, 1 mL 1M MgSO4, 1 mL 0.1M CaCl, and a final concentration of 0.15% 
cassamino acids) with ampicillin (100 µg/mL) was inoculated with a 20 mL overnight of 
cells in the same medium and grown 5 hours at 37° C at 220 rpm. Isopropyl β-D-1-
thiogalactopyranoside (IPTG) was then added to a final concentration 0.3 mM and incubated 
at 30° C for 3 hours. The cells were harvested at 4000 x g for 20 minutes and the supernatant 
was discarded. Cells were resuspended in 80 mL per gram of wet cell weight in 30 mM Tris-
HCl, 20% sucrose, pH 8.0. Ethylenediaminetetraacetic acid (EDTA) was added to 1 mM and 
incubated 10 minutes at room temperature with shaking. The cells were centrifuged at 8000 x 
g for 20 minutes at 4° C, the supernatant was removed, and the pellet was resuspended in the 
same amount of ice-cold 5 mM MgSO4 and shaken for 10 minutes in an ice-bath. The cells 
were centrifuged at 8000 x g for 20 minutes at 4° C, and the supernatant, which contained the 
periplasmic fraction, was collected. To the supernatant, 8 mL of 1 M Tris-HCl (pH7.4) and 
0.1 M phenylmethanesulfonylfluoride (PMSF) final concentration was added. Four mL of 
amylose resin was equilibrated with column buffer (20 mM Tris, 200 mM NaCl, and 1 mM 
EDTA) and added to the supernatant for incubation overnight at 4°C. The slurry was then 
centrifuged at 4700 x g for 10 minutes multiple times to collect the resin into one conical 
tube. The resin was then loaded on a column and washed with 12 mL of column buffer. The 
protein was eluted with 10 mL column buffer containing 10 mM maltose. One mL fractions 
were collected, fractions containing protein were determined using a Bradford assay, and 
visualized using SDS-PAGE. These fractions were pooled and concentrated to 1 mg/mL, and 
stored with 50% glycerol at -20° C.  
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Table 1. Bacterial strains.     
 
Strains   Genotype      Reference/source       
E. coli 
 DH5α   F-φ80lacZ∆M15, ∆(lacZYA-argF)U169, deoR,recA1,   Invitrogen 
     phoA, endA1, hsdR17(rk2, mk+), supE44, thi-1, gyrA96, 
                                                   re/A1, λ- 
SM10λpir   thi thr leu tonA lacY supE recA<RP4-2-Tc<MulpirR6K;                          Miller & Mekalanos  
                                                                                                                                                                  (1988) 57 
NEB Express  Kmr fhuA2 [Ion] ompT gal sulA11 2    New England Biolabs 
     R(mcr-73::miniTn10—TetS) [dcm] 
  R(zgb-210::Tn10—TetS) endA1 ∆(mcrC-mrr)114::IS10 
V. cholerae 
PW249   MO10, clinical isolate of V. cholerae O139 from India SmR                     Waldor & Mekalanos 
                                                                                                                                                                  (1994) 58 
PW357   MO10lacZ::vpsLp → lacZ, SmR                   Haugo & Watnick 
                                                                                                                                                                  (2002) 59 
AK059   MO10∆potD1, SmR                      McGinnis et al. (2009) 12 
AK160   PW357∆potD1, SmR     This study 
AK164   PW357∆potD1 w/ pACYC184, TetR    This study 
AK103   MO10 w/ pACYC184     This study 
AK314   PW357∆nspC, SmR      This study 
AK317   PW357∆potD1∆nspC, SmR     This study 
AK165   MO10∆potD1 w/ pAR2     This study 
AK214   MO10∆potD1 w/ pAR6     This study 
AK268A   MO10∆potD1 w/ pAR13     This study 
AK205   MO10∆potD1 w/ pAR8     This study 
AK213   MO10∆potD1 w/ pAR7     This study 
AK266B   MO10∆potD1 w/ pAR11     This study 
AK330   PW357∆potD1∆nspC W/ pAR6    This study 
AK331   PW357∆potD1∆nspC w/ pAR7    This study 
AK332   PW357∆potD1∆nspC w/ pAR11    This study 
AK326   PW357∆potD1∆nspC w/ pAR8    This study 
AK327   PW357∆potD1∆nspC w/ pAR13    This study 
AK333   PW357∆potD1∆nspC w/ pAR2    This study 
 
 
Table 2. Bacterial plasmids. 
 
Plasmids  Genotype                  Reference/source 
pCR2.1-TOPO  TOPO cloning plasmid, ApR     Invitrogen 
pACYC184  cloning plasmid, low copy, TetR    New England Biolabs 
pGEM-T   pGEM-T easy cloning vector, ApR    Promega 
PWM91   oriR6k, lacZα, sacB, homologous recombination plasmid, ApR Metcalf et al. (1996) 39 
pKD4   template plasmid, ApR, KanR                Datsenko & Wanner                                
         (2000) 60 
pMAL-p5X  protein expression plasmid, ApR    New England Biolabs 
pAR1   pGEMT::potD1V5      This study 
pAR2   pACYC184::potD1V5     This study 
pAR6   pACYC184::potD1 (E168A)     This study 
pAR7   pACYC184::potD1 (W252L)     This study 
pAR8   pACYC184::potD1 (D254N)     This study 
pAR11   pACYC184::potD1 (D254A)     This study 
pAR13   pACYC184::potD1 (W32L)     This study 
pAR14   pMAL-p2X:: potD1      This study 
pAR18   pMAL-p2X:: potD1 (W252L)     This study 
pAR17   pWM91::Kan cassette w/ flanking nspC regions   This study 
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Table 3. Primers. 
 
Primer    Description     Sequence 
PA138  Forward primer for the potD1 gene  5’- ACGCCTAGTTAGGTTCTTTC-3’ 
PA144  Reverse primer for the potD1 gene   5’CCATGGCTACGTAGAATCGAGACCGAGGA 
   with a V5 tag         AGGGTTAGGGATAGGCTTACCGCCGCTGC 
        CGCT GCCATCGTTCACTTTTAGCTTTTGG-3 
PA182  Reverse primer for the potD1 gene  5’- CCATGGCTACGTAGAATCG-3’ 
PA167  W32L mutant forward primer   5’-CTTTATTTCTACAACCTGTCTGAATATATC-3’ 
PA168  W32L mutant reverse primer   5’-GATATATTCAGACAGGTTGTAGAAATAAAG-3’ 
PA169  E168Q mutant forward primer    5’-GATGACGCTCGTCAAGTCTTCCATATC-3’ 
PA170  E168Q mutant reverse primer    5’-GATATGGAAGACTTGACGAGCGTCATC-3’ 
PA171  E168A mutant forward primer     5’-GATGACGCTCGTGCAGTCTTCCATATC-3’ 
PA172  E168A mutant reverse primer   5’-GATATGGAAGACTGCACGAGCGTCATC-3’ 
PA173  W252L mutant forward primer   5’-CACCATTTTTCTGATGGACAGCATC-3’ 
PA174  W252L mutant reverse primer   5’-AGTGCTGTCCATCAGAAAAATGGTG-3’ 
PA175  D254N mutant forward primer                  5’-CATTTTTTGGATGAACAGCATCTCGATTC-3’ 
PA176  D254N mutant reverse primer                               5’-GAATCGAGATGCTGTTCATCCAAAAAATG-3’ 
PA177  D254A mutant forward primer                  5’-CATTTTTTGGATGGCCAGCATCTCGATTC-3’ 
PA178  D254A mutant reverse primer                  5’-GAATCGAGATGCTGGCCATCCAAAAAATG-3’ 
PA193  pMalp2X PotD1 forward primer  5’-AAAGACCAAGAACTTTATTTCTAC-3’ 
PA194  pMalp2X PotD1 reverse primer  5’-CGCCCATGGTTAATCGTTCACTTTTAGC-3’ 
PA207                        NspC deletion pKD4                                  5’TGCGGCCGCTCGTAACAA 
 amplification forward primer                     GAGACAGGATGAGGATC-3’ 
PA208                   NspC deletion pKD4 Reverse primer        5’-TTACGAGCGGCCGCATCA 
         GAAGAACTCGTCAAGAAG-3’ 
P328  Upstream nspC deletion forward primer                  5’-GTGTATTCAATATGGAGCAGC-3’ 
P329   Upstream nspC deletion   5’-TTACGAGCGGCCGCACA 
 reverse soe primer                       TGAAGTATGGGGTTCTC-3’ 
P330  Downstream nspC deletion                  5’-TGCGGCCGCTCGTAAAATGGC 
  forward soe primer                             CTGAAAATGCCGTCG-3’ 
P331  Downstream nspC deletion reverse primer             5’-TCTAAGCAGCGTTCAGAAGC-3’ 
 
 
 
 
 
 
 
 
 
 
 
 
 
  18 
 
 
 
 
RESULTS 
 
Construction of a V. cholerae mutant unable to synthesize norspermidine 
Because V. cholerae is able to synthesize norspermidine, I first constructed a strain 
unable to synthesize this molecule in order to assess norspermidine import. Multiple attempts 
to delete the nspC gene in V. cholerae, to ensure that V. cholerae could not synthesize 
norspermidine, have been unsuccessful. For example, an attempt was made to replace the 
nspC gene with a markerless in-frame deletion which failed (42). In addition, I attempted to 
use ʎ-Red phage recombineering to delete this gene with no success. These initial failures 
suggested that the deletion of the nspC gene may affect cell health; therefore, we decided to 
use a positive selection system utilizing an antibiotic resistance gene. Homologous 
recombination using SacB counter-selectable mutagenesis was used to delete the nspC gene, 
but only with the addition of an antibiotic selection marker (Figure 5).  
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Figure 5. Scheme representing the construction of the pAR17. The pAR17 conjugation 
plasmid was used to replace the nspC gene in V. cholerae with a kanamycin resistance 
marker. The primer sequences are listed in Table 3. SOE presence indicates complementary 
regions. 
 
First, a linear construct missing the nspC gene and containing the kanamycin 
acetyltransferase cassette was constructed. A region upstream of the nspC gene was 
amplified using P328 and P329, resulting in a 338 bp fragment, lane 3 on figure 6. A region 
downstream of the nspC gene was amplified using P330 and P331, resulting in a 468 bp 
fragment, lane 6 figure 6. In order to splice the three pieces using overlap extension PCR 
(SOE), primers P329 and P330 were engineered with SOE tags which were complementary 
to the SOE tags on the primers, PA207 and PA208,  used for amplification of the 822 bp 
kanamycin acetyltransferase cassette from the pKD4 plasmid, lane 4 figure 6 (Figure 6). This 
allowed the upstream and downstream fragments to be spliced to the kanamycin 
PA207 
PA208 
P328 
P329 
P330 
P331 
P328 
P331 
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acetyltransferase cassette using the outside P328 and P331 primers, resulting in a 1780 bp 
fragment, lane 3 figure 7 (Figure 7). In this construct, the majority of the nspC coding 
sequence has been removed and replaced by the kanamycin acetyltransferase cassette. 
Adenines were added and this insert was cloned into a pCR2.1 TOPO plasmid, making use of 
the thymine overhangs using manufacturer’s instructions, and verified using colony PCR 
with the M13 forward and reverse primers (Figure 8). After verification of the sequence, one 
plasmid isolated from a clone was digested and inserted into a linearized pWM91 plasmid 
(Figure 9), resulting in the pAR17 conjugation plasmid. Presence of the insert was confirmed 
using colony PCR (Figure 10) and this plasmid was mobilized into V. cholerae wild-type 
cells using homologous recombination with SacB counterselectable mutagenesis as described 
in the methods. The kanamycin and streptomycin resistant, ampicillin sensitive colonies were 
used to confirm the presence of the ∆nspC::kan construct by colony PCR (Figure 11).  
 
Figure 6. A gel electrophoresis of pAR17 fragment excision. This image depicts the 3 
separate fragments used for construction of the linear segment of DNA containing the KanR 
cassette. The lanes are as follows: lane 1 is the 2-log ladder, lane 3 is the upstream 338 bp 
fragment, lane 4 is the 822 bp KanR cassette, lane 6 is the downstream 468 bp fragment, and 
lanes 2 and 5 are empty. The black boxes indicate excised fragments. 
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Figure 7. Gel electrophoresis of the pAR17 fused product. This image represents the 
fused product of both upstream and downstream pieces with the KanR cassette. Lane 2 
represents the 2-log ladder and lane 3 indicates the fused product at 1780bp.  
 
 
Figure 8. Colony PCR of ∆npsC::kan. Lane 1 is the 2-log ladder, lanes 2-9 are individual 
colonies and the brightest band is representative of the 1781 bp band. Lane 2 was chosen for 
further manipulation.  
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Figure 9. Gel electrophoresis of the undigested and digested plasmids. The lanes are as 
follows: lane 1 is the 2-log ladder, lane 2 the undigested ∆nspC::kan  linear construct in the 
plasmid vector, lane 3 the digested ∆nspC::kan  linear construct, lane 4 is empty, lane 5 is 
pWM91 undigested plasmid, and lane 6 is pWM91 digested plasmid. The black boxes 
indicate excised fragments.  
 
 
Figure 10. Colony PCR of ∆npsC::kan in the pWM91 vector. Lane 1 represents the 2-log 
ladder, lane 2 is a colony positive for the insert, lanes 3-7 are colonies in which the insert was 
not present or did not amplify. Lane 8 represents wild-type V. cholerae nspC amplification. 
Lane 9 and 10 are empty. The primers used were P331 and P328.  
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Figure 11. Colony PCR confirmation of nspC deletion. This gel is representative of the 
same colonies under two different conditions. The first and eleventh lane represent the 2-log 
ladder. Lanes 3-10 are the colonies amplified with P328 and P208 resulting in a 1312 bp 
band, used as a control to indicate colony amplification was possible. Lanes 13-20 are 
identical colonies amplified with the P328 and P331 primers resulting in a 1780 bp band. 
Lanes 2 and 12 are a wild-type V. cholerae and the nspC gene is amplified in lane 12 with a 
1787 bp band.  
 
Confirmation of the lack of norspermidine present in V. cholerae ∆nspC  
To confirm the ∆nspC::kan mutant was deficient in synthesizing norspermidine, high 
performance liquid chromatography (HPLC) was used to determine the polyamine levels 
present in the cells. A standard polyamine mix containing putrescine, diaminopropane, 
cadaverine, norspermidine, and spermidine, respectively, were quantified (Figure 12A) and 
peak retention times were compared to the wild-type V. cholerae (Figure 12B) and V. 
cholerae ∆nspC mutant (Figure 12C). The ∆nspC mutant was deficient in its ability to 
synthesize norspermidine, confirming the deletion of the nspC gene.  
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Figure 12. Confirmation of a lack of norspermidine using HPLC. A) HPLC 
chromatogram depicting the retention times of each polyamine. The peaks are representative 
of putrescine, diaminopropane, cadaverine, norspermidine, and spermidine, respectively. B) 
HPLC chromatogram representing wild-type V. cholerae. C) HPLC chromatogram 
confirming a lack of norspermidine in the V. cholerae ∆nspC mutant.  
 
 
 
Identification of a norspermidine transporter 
In order to assess the ability of PotD1 to act as a norspermidine transporter, first a 
double mutant was constructed. Homologous recombination was used to delete the potD1 
gene from the V. cholerae ∆nspC mutant in the same manner as previously stated. Because V. 
cholerae cannot synthesize much spermidine under these conditions, the cellular spermidine 
results from the import of spermidine in the media. Therefore, a ∆nspC∆potD1 double 
mutant should not contain any spermidine or norspermidine. This hypothesis was explored 
through the quantification of intracellular polyamines using HPLC, as previously stated, and 
it was confirmed that no spermidine or norspermidine was present in this mutant (Figure 13).  
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Figure 13. Polyamines present in the V. cholerae ∆nspC ∆potd1 mutant using HPLC. 
The polyamines present are putrescine, diaminopropane, and cadaverine, respectively.  
 
 
The polyamine retention times were compared to the standard polyamine retention times 
(Figure 12A). Upon confirmation of the inability of the V. cholerae ∆nspC ∆potd1 mutant to 
uptake spermidine, the potential of PotD1 to act as a norspermidine transporter was explored. 
The V. cholerae ∆nspC strain containing the wild-type PotD1 protein was used to determine 
the ability of this protein to transport norspermidine. With the addition of 1 mM 
norspermidine to the media, a norspermidine peak was confirmed and the spermidine peak 
was no longer present (Figure 14). These results were also previously seen in wild-type V. 
cholerae, with the addition of 1mM norspermidine to the media, suggesting spermidine 
import is being blocked through PotD1 in the presence of norspermidine. To ensure that 
norspermidine was imported into the cell by PotD1 and not by a different low affinity 
transporter, polyamines in a ∆npsC∆potD1 mutant grown in the presence of 1 mM 
norspermidine were quantified. This mutant was not able to import norspermidine, indicating 
that PotD1 is responsible for norspermidine import (Figure 15). These results established the 
role of PotD1 to act as a substrate binding protein to both spermidine and norspermidine.  
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Figure 14. V. cholerae ∆nspC mutant with 0 mM Nspd and with 1 mM Nspd.  
Norspermidine is represented as Nspd. The dashed line represents 0 mM Nspd. The gray line 
represents 1 mM Nspd.  
 
 
 
Figure 15. V. cholerae ∆nspC ∆potd1mutant with 1 mM Nspd. The peaks present are 
putrescine, diaminopropane, and cadaverine, respectively.  
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PotD1 preferentially binds spermidine over norspermidine 
In order to assess the affinity of PotD1 for spermidine and norspermidine, 
competition assays were performed. The V. cholerae ∆nspC strain was grown with varying 
amounts of norspermidine added exogenously. The exogenous spermidine present in the LB 
media was quantified by benzoylation and HPLC. It was determined that spermidine was 
present at 10 +/- 13 uM in the environment (Figure 16 D), and the addition of 1 uM, 100 uM, 
and 1 mM exogenous norspermidine allowed for the characterization of PotD1 affinity for 
norspermidine and spermidine (Figure 16 A and B). Addition of 1 and 100 uM of 
norspermidine did not result in uptake of norspermidine, suggesting that PotD1 has a 
substantially higher affinity for spermidine than norspermidine (Figure 16 A and B). 
Norspermidine uptake occurred only upon the addition of 1 mM norspermidine, which is 
approximately 100 fold in excess to spermidine (Figure 16 C). These results show spermidine 
has a higher binding affinity to PotD1 than norspermidine, indicating that spermidine is the 
preferred ligand for the PotABCD1 transporter. 
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Figure 16. HPLC of media conditions and V. cholerae ∆nspC mutant with added 
norspermidine. A) HPLC chromatogram representative of the V. cholerae ∆nspC mutant 
with 1µM exogenous norspermidine. B) HPLC chromatogram of the V. cholerae ∆nspC 
mutant with 100 µM exogenous norspermidine. C) HPLC chromatogram the V. cholerae 
∆nspC mutant with 1 mM exogenous norspermidine. The spermidine (SPD) peak is present 
at 1 µM and 100 µM norspermidine, but diminished and replaced with norspermidine 
(NSPD) at 1mM. D) HPLC chromatogram representing the polyamines present in the growth 
medium. 
 
 
Identification of residues important for spermidine binding 
The PotD1 protein of V. cholerae shares a 62% identity with the PotD protein of E. 
coli as predicted by sequence alignment using ClustalW (Figure 17A). The PotD protein of 
E. coli has been extensively characterized both through the identification of amino acids 
involved in polyamine binding and the crystal structure of PotD complexed with spermidine 
(26, 38). The V. cholerae PotD1 protein was characterized by mutating amino acids which 
are conserved between the E. coli PotD and V. cholerae PotD1 and have been shown to be 
A B 
C D 
SPD SPD 
SPD 
NSPD 
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strongly involved  in the binding of spermidine to the E. coli PotD binding site (26). 
Sugiyama et al. classify this protein as having two dynamic domains with the binding cleft 
situated between these domains. The E. coli PotD cleft has four acidic residues (Glu 36, Asp 
168, Glu 171, and Asp 257) that interact with protonated spermidine, and five aromatic side 
chains (Trp 34, Tyr 37, Trp 255, Tyr 293, and Trp 229) that anchor the carbon backbone 
through Van der Waals interactions (38), but the residues W34, E171, W255, and D257 were 
shown to have the most drastic effect on spermidine binding (26). The homology model of 
PotD1 suggests a similar topology and ligand interaction in V. cholerae (Figure 17 B and C). 
To determine where these amino acids might be located in the 3D structure of V. cholerae 
PotD1, I made use of a homology model. A 3D representation of the PotD1 protein in V. 
cholerae was modeled using the PotD protein of E. coli complexed with spermidine in the 
dimer form as a template (Figure 17B). A magnified view of the PotD1 binding cleft shows 
the amino acids that are conserved in PotD and have been shown to play an important role in 
interaction with spermidine at the binding cleft of PotD in E. coli. Therefore, I hypothesized 
that the following amino acid residues would contribute to the ability of PotD1 to bind 
spermidine and norspermidine: W32, E168, W252, and D254, which are identified with 
arrows in figures 17A and C (Figure 17 A and C).  Kashiwagi et al. (26) reported that the 
tryptophan in E. coli, correlating to the W32 residue in V. cholerae, had decreased uptake 
activity of spermidine and putrescine binding. I hypothesized that this residue is stabilizing 
the polyamine binding due to the electrostatic interactions between the electron dense rings 
of tryptophan and the amine of the polyamine, and that altering the amino acid to a leucine 
would decrease polyamine binding but still confer some stability from the methyl groups of 
leucine. The E168 and D254 residues were changed to alanines to show that glutamic acid at 
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position 168 and aspartic acid at position 254 are directly involved in stabilization of the 
amine groups within the polyamine, and when there is only one methyl group from the 
alanine available for interaction with the ligand, binding should be reduced. The D254 
residue was also altered to an asparagine to show that normal binding would be reduced due 
to the charge repulsion between the amine groups on asparagine and the polyamine.  The 
W252 residue was altered to a leucine because it is thought that the tryptophan contributes to 
spermidine stability within the cleft due to the pi bonds interacting with the positively 
charged polyamine; and leucine, with two methyl groups, would be better tolerated in that 
position rather than alanine with one methyl group. 
 
A 
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Figure 17. PotD1 alignment and homology model. A) The alignment of V. cholerae PotD1 
and E. coli PotD proteins. The arrows indicate the homologous amino acid residues chosen 
for site-directed mutagenesis.  B) The predicted PotD1 protein model. SWISS-MODEL was 
used for homology structure determination using 1POY as a template. MOLSOFT ICM 
Browser was used to depict structure. This image is colored by secondary structure, red = α-
helices and green = β strands (38). C) A magnified view of the PotD1 binding cleft modeling 
amino acid side chains that are predicted to have a direct impact on the ligand binding 
interaction of PotD1 as compared to the E. coli PotD (26). The amino acids chosen to have a 
direct impact in the Vibrio system are labeled.  
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Construction of the potD1 mutants  
To further understand the role of certain amino acids within the PotD1 binding cleft, 
PCR mutagenesis was used to mutate specific residues within the potD1 gene, corresponding 
to W32L, E168A, W252L, D254A, and D254N. Representative experimental data obtained 
during the construction of one of these mutants, W252L, is shown in figures 18-21. 
Mutagenic forward and reverse primers were designed to alter each amino acid residue 
(Table 3) and encoded complementary sequences that allowed the fusion of each amplified 
piece of the potd1 gene (Figure 18). For example, each mutant was constructed by 
amplifying both upstream and downstream fragments using mutagenic and outside potD1 
primers, excised (Figure 19), and fused (Figure 20) using the outside potD1 primers, PA 138 
and PA144. The mutated genes were cloned into a pCR2.1 TOPO vector, transformed into E. 
coli, and the presence of potD1 was confirmed using colony PCR (Figure 21); the presence 
of the mutation was confirmed by sequencing. The inserts were liberated from pCR2.1 and 
subcloned into pACYC184 as described in the Materials and Methods. Presence of the insert 
in pACYC184 was confirmed using colony PCR. A Western blot using the V5 epitope tag 
engineered to each mutant showed that the mutant genes expressed at the same level as the 
wild-type gene (Figure 22). 
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Figure 18. Visual representation depicting PCR mutagenesis of each mutant. The 
triangle on primer D represents an epitope tag engineered to the reverse primer for 
amplification of the potD1 gene. The middle primers, B and C, represent the mutagenic 
primers encoding complementary regions for stitching together the PCR products. The 
mutants were first cloned into a pCR2.1 TOPO vector before being put into the pACYC184 
vector.  
 
  35 
 
 
Figure 19. Gel electrophoresis representing the W252L mutagenic fragments. The first 
lane is the 2-log ladder. Lane 3 and 5 are representative of the upstream and downstream 
fragments. The rest of the lanes are empty.  
 
Figure 20. Gel electrophoresis representing the W252L mutant potD1 fused gene 
sequence. Lane 1 is the 2-log ladder and lane 3 represents the 1100 bp fused mutant 
sequence. 
  
 
Figure 21. Colony PCR of the W252L mutant in the pCR2.1 TOPO vector. Colony PCR 
was performed using primers PA138 and PA144. The first lane is the 2-log ladder. The 
second lane is a positive control and the respective lanes are individual colonies.  
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Mutations in the putative binding cleft residues do not alter expression  
Our results confirm that expression was uniform among all mutants. Comparison of 
wild-type PotD1 expression to mutant PotD1 expression showed that no difference in 
expression was noticed among the mutants (Figure 22).  
Figure 22. Western Blot showing expression of PotD1 mutants. Mutants were detected 
using the V5 epitope tag. The size of protein in each lane is 40 kDa. Lane 1 is the D254N 
mutant, Lane 2 is the D254A mutant, Lane 3 is the E168A mutant, Lane 4 is the W32L 
mutant, Lane 5 is the W252L mutant, and Lane 6 is the ∆potD1 w/ PotD1.   
 
 
Mutations in the PotD1 binding cleft affect spermidine uptake 
To assess the effect of mutating the amino acid residues W32, E168, D254, and 
W252 on spermidine binding to PotD1, the intracellular spermidine levels were quantified in 
cells containing these protein variants (Figure 23). Spermidine levels in the ∆potD1 strain, 
expressing the wild-type potD1 gene from a medium copy plasmid (15-20 copies), were 
similar to those in the wild-type V. cholerae with a single chromosomal potD1 gene. Because 
the pACYC184::potD1 construct fully restored spermidine uptake, any reduction in the levels 
of spermidine containing the potD1 mutants can be attributed to the mutations rather than 
other secondary factors (Figure 23). Therefore, the amount of spermidine in the mutants was 
compared to the complementation strain with wild-type PotD1 reintroduced into the ∆potD1 
strain (Table 4).  
Mutations in the W252 amino acid residue were detrimental to the uptake of 
spermidine and the W252L mutant behaved similarly to the ∆PotD1 strain (Figure 23). The 
amount of intracellular spermidine was approximately 3% compared to the amount of 
1                         2                          3                           4                        5 6
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spermidine uptake supported by wild-type PotD1 (Table 4). The D254 amino acid residue 
was just as important in contributing to spermidine uptake (Figure 23). Spermidine import for 
D254N and D254A was 5% and 6% respectively, of the total intracellular spermidine uptake 
supported by the wild-type PotD1 (Table 4). In contrast, the W32 and E168 residues were not 
as important in spermidine binding, and these mutants were still able to support uptake of 
spermidine, although uptake was considerably decreased when compared to wild-type PotD1 
(Figure 23); both W32L and E168A mutations allowed for only about 20% of spermidine 
uptake compared to wild-type PotD1 (Table 4). Thus, the W252L, D254A, and D254N 
mutations are detrimental to spermidine uptake and E168A and W32L mutations are more 
tolerated. These results suggest that W252 and D254 amino acids are the most important for 
spermidine binding to PotD1, and the E168 and W32 amino acids are of secondary 
importance.  
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Figure 23. Spermidine presence in wild-type and mutated PotD1 protein. The average 
spermidine amounts present in cells containing wild-type or mutated PotD1 protein. Standard 
deviation is representative of multiple replicates (2-4 replicates). All strains contain either the 
empty pACYC184 vector or the same vector with the specified mutants cloned into it. A 2-
tailed t-test was used to determine statistical significance of differences compared to ∆potD1 
w/ PotD1. Differences with p values less than 0.05 were deemed significant and are indicated 
with a star. 
 
 
Mutations in potD1 alter the biofilm phenotype in V. cholerae  
Because PotD1 directly affects biofilm formation in V. cholerae, the biofilm 
phenotypes of the mutants were explored. If PotD1 is not present in V. cholerae, biofilm 
formation is drastically increased compared to wild-type V. cholerae (Figure 24). Because 
PotD1 is responsible for spermidine uptake, this result suggested intracellular spermidine 
presence was the key factor in biofilm formation. To determine if the ability of the mutants to 
uptake spermidine correlated with inhibition of biofilm formation, the effect of the mutations 
on biofilm formation was assessed. I hypothesized that the mutants that only allowed 
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minimal spermidine uptake, such as W252L, D254A, and D254N, would not complement the 
biofilm phenotype and would look similar to the ∆potD1 strain.  I also hypothesized that the 
mutations that allowed reduced uptake of spermidine, W32L and E168A, would lead to a 
partial complementation of biofilm phenotype. Biofilm formation among all of the mutants 
was increased, as compared to wild-type V. cholerae and also ∆potD1 with PotD1. This 
increase is also seen in ∆potD1, albeit the increase is much higher compared to the mutants. 
Although the W252L, D254A, and D254N mutants are unable to uptake spermidine (Figure 
23, Table 4), the biofilm formed does not increase to levels seen in the ∆potD1 mutant, 
which would have been expected if spermidine was the only variable behind this biofilm 
phenotype. Overall, the biofilm phenotype of each mutant did not correlate to the expected 
biofilm phenotype based upon their ability to uptake spermidine, but the increase in biofilm 
formation compared to wild-type PotD1 does advocate that spermidine import plays a role in 
biofilm formation, considering all mutants are lacking in their ability to uptake spermidine 
(Figures 23 and 24). These results also suggest that spermidine, being bound by PotD1 and 
transported, may not be the only influence on biofilm formation in V. cholerae as previously 
seen. Instead the PotD1 protein may be playing a direct role in regulation of biofilm 
formation by a yet unidentified mechanism.   
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Figure 24. Biofilm formation of PotD1 mutants, wild-type PotD1, and ∆PotD1. Biofilm 
formation of PotD1 mutants is compared to wild-type PotD1 and a strain without PotD1. The 
biofilms were grown for 34 hours and this data is representative of four replicates. Error bars 
indicate standard deviation. A two-tailed t-test was used to determine if the differences seen 
are significant compared to ∆potD1 w/ pACYC184, shown with gray stars, and to determine 
significance compared to ∆potD1 w/ PotD1, shown with a crescent. Differences were 
deemed significant for p values less than 0.05.  
 
 
Table 4. Spermidine uptake and biofilm formation of each mutant and ∆PotD1 
compared to wild-type PotD1. Numbers are given as averages with standard deviations. 
  Spermidine uptake (% WT) Biofilm (fold WT) 
W32L 20 +/- 17.5 7 +/- 0.05 
E168A 20 +/- 4.2 4 +/- 0.06 
W252L 3 +/- 2.42 4 +/- 0.05 
D254A 6 +/- 1.0 7 +/- 0.09 
D254N 5 +/- 4.8 5 +/- 0.05 
∆PotD1 2 +/- 1.3 18 +/- 0.09 
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Construction and purification of a periplasmic expression protein for potD1  
To determine the binding affinity of the PotD1 protein to its respective ligands, 
norspermidine and spermidine, a recombinant PotD1 expression protein was engineered 
using the pMAL Protein Fusion and Purification System (Figure 25). In this system the gene 
of interest is cloned into the above vector in frame with the maltose binding protein (MBP), 
enhancing the stability and solubility of foreign proteins expressed in E. coli. 
 
Figure 25. Visual representation of the MBP-PotD1 fusion protein construction. The 
malE sequence codes for the MBP protein. A polylinker joins the malE and potd1 gene 
sequences. The lacI repressor and Ptac promoter sequences allow for induced transcription 
by the allolactose mimic, IPTG. The bla gene encodes ampicillin resistance.  
 
pMALp-5X 
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The potD1 gene was amplified using primers PA193 and PA194, and utilized the signal 
sequence of the pMAL-p5X vector for periplasmic localization (Figure 26). The potD1 gene 
was restricted, purified, ligated into pMAL-p5X, and transformed into NEB E. coli (Figure 
27). Presence of the insert was verified and a clone with the insert was sequenced to confirm 
correct construction. This plasmid was used for expression and purification of MBP-PotD1 
fusion protein. A single band of ~ 80 kDa, corresponding to the expected molecular weight 
of the fusion protein, can be seen (Figure 28). Purification of the MBP-PotD1 fusion protein 
in polyamine deficient media was necessary and produced a purer periplasmic content 
(Figure 29). The mutant W252L PotD1 protein was also fused, in a similar manner, with the 
MBP protein as confirmed by the ~ 80 kDa band present in Figure 30; this mutant was 
chosen because of its diminished spermidine uptake and should not exhibit the same binding 
kinetics as wild-type PotD1. A Bradford assay and SDS page confirmed protein presence and 
these fractions were pooled and concentrated to 1 mg/mL (Figures 28-30). 
 
Figure 26. Gel Electrophoresis of potD1 without its signal sequence. Lane 1 is the 2-log 
ladder and lane two represents the ~ 970 bp band.  
 
 
1 2 3 4 5 6  
1.0 kb
1.0 kb 
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Figure 27. Colony PCR confirming the potD1 in the pMALp-5X vector. Lane 1 is the 2-
log ladder and lanes 3-10 represent individual colonies which are all positive for the insert. 
Figure 28. Polyacrylamide denaturing gel of MBP-PotD1 expression and purification. 
Lane 1 represents the ColorPlus Prestained Protein Marker (7-175 kDa), lane 2 is the 
uninduced cell extract, lane 3 is the induced cell extract, lane 4 is the column wash flow 
through, lanes 5-10 are fractions collected during purification. 
 
Figure 29. Denaturing polyacrylamide gel of the MBP-PotD1 fusion protein in M9 
minimal media. Lane 1 represents the ladder and lanes 2-10 represent collected fractions 
containing the fusion protein. Fractions containing the fusion protein were pooled together 
and stored for further analysis. 
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Figure 30. Denaturing polyacrylamide gel of the MBP-W252L fusion protein in M9 
minimal media. Lane 1 represents the ladder and lanes 2-10 are the fractions containing the 
fusion protein. Fractions containing the fusion protein were pooled together and stored for 
further analysis.  
 
Determining the binding kinetics of PotD1  
Preliminary data with the PotD1 fusion protein, using Differential Scanning 
Flourimetry (DSF), shows stabilization with both norspermidine and spermidine (data not 
shown), suggesting PotD1 can bind both of these. However, Isothermal Titration Calorimetry 
(ITC) will be used to quantify the binding affinity of PotD1 to spermidine and 
norspermidine, if time permits. It is predicted that the PotD1 protein binding association will 
follow a 1:1 stoichiometric relationship with the ligand positioning itself in the predicted 
binding cleft of PotD1 (Figure 17). Determining the binding affinity of PotD1 to its ligands 
will allow for a more detailed characterization of the specificity that PotD1 possesses for 
both norspermidine and spermidine binding. 
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DISCUSSION 
 
The purpose of this study was to characterize the ability of the periplasmic PotD1 
substrate binding protein to interact with spermidine and norspermidine, while exploring its 
influence on biofilm formation in the pathogen V. cholerae. This work establishes PotD1 as 
the first norspermidine transporter ever reported in any species. Previous results, in wild-type 
V. cholerae, demonstrated the potential competition of norspermidine to spermidine for 
binding to the PotD1 protein and presented the background for elucidating the role of PotD1 
in V. cholerae (12). The importance of norspermidine to V. cholerae has been demonstrated 
and indicates the prominence of this molecule in varying aspects of V. cholerae physiology. 
The ability for PotD1 to uptake norspermidine indicates that this molecule is important 
enough to import from the extracellular environment, even when V. cholerae is able to 
synthesize norspermidine. Norspermidine can also act to upregulate biofilms (41), and 
growth and biofilm formation is impaired when V. cholerae is not able to synthesize 
norspermidine (24). The cellular need for norspermidine is also indicated by the ability of V. 
cholerae to utilize this molecule as the backbone in vibriobactin synthesis. The vibriobactin 
siderophore is used to scavenge and acquire ferric iron for various cellular processes and its 
performance is necessary to proper cell function (43, 44). Therefore, norspermidine is 
important for V. cholerae cell health. This research also demonstrates that PotD1 is the only 
norspermidine transporter as in the absence of PotD1 norspermidine transport is completely 
abolished. 
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Interestingly, while PotD1 is capable of transporting norspermidine, its preferred 
ligand is spermidine. V. cholerae does not synthesize much spermidine, although nspC can 
use putrescine under certain conditions instead of diaminopropane to synthesize spermidine 
instead of norspermidine. The lack of a robust spermidine synthesis pathway may lead to the 
hypothesis that V. cholerae does not utilize spermidine in cellular processes. However, the 
presence of a high affinity transport system that prefers spermidine over norspermidine 
argues against this hypothesis. It is likely that spermidine is an important molecule for V. 
cholerae and regulates aspects of its physiology that have not yet been determined. It is 
known that spermidine influences the cell in an opposite manner as norspermidine to regulate 
biofilms (11), but there may also be other intracellular effects that have yet to be elucidated.  
This work also focused on understanding the PotD1 protein through a detailed 
biochemical characterization. A hypothesized model of the PotD1 protein predicts that the 
binding association will follow a 1:1 stoichiometric relationship with the ligand positioning 
itself in the predicted binding cleft of PotD1 between the N-terminus and C-terminus 
globular domains (35, 36, 37). Mutation of the W252 and D254 amino acid residues were 
detrimental to the binding of spermidine and the PotD1 proteins altered in these amino acids 
were still able to support uptake of spermidine, although uptake was considerably decreased 
(Figure 23). In contrast, the W32 and E168 residues were not as important in spermidine 
binding, and these mutants were still able to support uptake of spermidine, although uptake 
was considerably decreased when compared to wild-type PotD1 (Figure 23). Thus, the 
W252L, D254A, and D254N mutations are detrimental to spermidine uptake and E168A and 
W32L mutations are more tolerated. This suggests that the W252 and D254 amino acids are 
the most important for spermidine binding to PotD1 and the E168 and W32 amino acids are 
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of secondary importance. These results coincide with the biochemical characterization of the 
PotD protein in E. coli, with slight variations. The E171, W255, and D257 residues 
(analogous to E168, W252, and D254, of PotD1, respectively) were detrimental to 
spermidine binding in E. coli and W34 was used to a lesser extent (26). It is worth 
mentioning that the polyamine concentrations calculated in this mutant deviated drastically 
between the two trials performed and warrants another trial. Future experiments that are 
underway explore the effect of these mutations on norspermidine uptake and the relative 
affinities of PotD1 to spermidine and norspermidine using binding assays.  
This work also attempted to investigate the link between spermidine uptake and 
biofilm formation using the various PotD1 mutants that were generated. Despite their 
inability to support spermidine uptake, the mutants were still able to suppress biofilm 
formation (Figure 24). This suggests that PotD1 may regulate biofilm formation through 
spermidine uptake, as well as a distinct yet unidentified mechanism. One possibility for the 
unidentified mechanism may involve interaction of PotD1 with other polyamines, such as 
norspermidine. ABC transporter function can vary greatly among different species and their 
architecture is reflective of the role they play within the cell with the substrate binding 
domain being essential to transporter function. The transport system has the capacity to 
regulate many physiological processes due to the cellular influence of transported substrate, 
but it cannot be ruled out that the protein itself is playing a direct regulatory role within the 
cell (45, 32, 46). An example of this includes the PotD1 protein. Interestingly, PotD of E. coli 
has been shown to regulate gene expression of the PotABCD operon (46). To further 
understand the unidentified mechanism that is influencing PotD1 to regulate biofilm 
formation, a future direction may include putting these mutants back onto the chromosome as 
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a single copy and then reanalyzing the biofilms. This would eliminate the interpretation that 
biofilm regulation of the mutants is affected due to the higher levels of mutant protein 
expression and perhaps secondary effects.   
It is interesting to note that within the PotABCD2D1 system there are two 
hypothesized periplasmic binding proteins, PotD1 and PotD2. This is not an unusual 
characteristic considering multiple binding proteins with different binding specificities are 
able to utilize the same transporter system (47, 48). This work focused on understanding 
PotD1 function within the PotABCD2D1 system, but characterization of the whole system 
using bioinformatics allowed a more detailed understanding of PotD2 (Rutkovsky and 
Karatan, unpublished data), a very similar substrate binding protein as PotD1. This protein 
contains a sulphate/thiosulphate conserved binding site within the binding cleft, which may 
suggest sulfate transmembrane transporting activity. Interestingly, there are naturally 
occurring sulfonic acids within mammalian intestine such as taurine, and this molecule 
(C2H7NO3S) could be a likely candidate for PotD2 binding considering the amine group 
situated at the end of the linear molecule. The effect of taurine on biofilm formation of 
prokaryotic species has not yet been explored but warrants further investigation.  
Polyamines are essential molecules for most species, and this research also shows that 
PotD1 preferentially binds spermidine over norspermidine. Because norspermidine presence 
up-regulates biofilm formation (13) and spermidine presence decreases biofilm formation in 
V. cholerae, this suggests that PotD1 promotes polyamine uptake to regulate biofilm 
formation in environmental circumstances in which biofilm production is important: within 
the human host. The potential of this protein to alter binding function when norspermidine is 
present in high quantities illustrates the varying function this protein possesses to intake 
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molecules of necessity to the cell in certain circumstances. Although norspermidine 
concentration within the human intestine has not been characterized, dietary intake of 
polyamines to the gut lumen is on the order of about a millimolar per day (49), but 
polyamines such as spermidine are present in the micromolar range within the intestinal 
lumen (50, 51). This is especially interesting considering luminal polyamine content is being 
supplied at high concentrations yet present at low concentrations. This suggests that 
disappearance of polyamines from intestinal lumen may occur through rapid absorption, 
rapid degradation, or utilization in situ by both the human intestine and organisms that 
colonize this environment (52). It is thought that biofilm formation aids V. cholerae 
persistence in the stomach of the human host until the pathogen is able to reach the small 
intestine, which could suggest the role of PotD1 in recognition and uptake of polyamines in 
environments in which the polyamine content is considerably higher than the micromolar 
level, potentially the human stomach.  
The overwhelming emphasis V. cholerae places on norspermidine use, through 
detection, uptake, and synthesis, illustrates the need for complex regulatory systems to 
maintain norspermidine balance. Recent work has demonstrated that elevated levels of nspC 
enhance V. cholerae biofilm formation without affecting intracellular norspermidine 
concentrations (13). This indicates the potential presence of a feedback mechanism 
maintaining norspermidine homeostasis in V. cholerae. Interestingly, NspS, the 
norspermidine sensor protein, also regulates biofilm formation similarly through interaction 
with norspermidine, yet this phenomenon is independent of nspC expression and offers an 
alternative input into the biofilm regulatory network (13). 
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It should be noted that recent work has demonstrated the use of norspermidine, but 
not closely related polyamines, to prevent biofilm formation in B.subtilis, E. coli, and S. 
aureus (53), but this does not seem to be the case regarding the ability of V. cholerae to 
utilize norspermidine in biofilm regulation. It has been known that polyamines are utilized by 
most species for regulation, but the role of norspermidine to enhance biofilm formation by V. 
cholerae and inhibit biofilm formation by others further demonstrates the diverse strategies 
that different species use to interact with their host environment.  
The PotD protein is a known spermidine transporter in many species, including 
E.coli, Y. pestis, S. pneumonia, Synechocystis sp, P. aeruginosa, and V. cholerae (26, 16, 54, 
55, 12), but PotD1 homology among a diverse range of prokaryotes from different 
environmental niches (Figure 4) suggests its importance in cellular feats as well as ancestral 
evolutionary presence. It was recently shown by Joshi et al that S. aureus USA300 and other 
bacterial species have lost their polyamine biosynthesis genes over the course of evolution 
(56), but interestingly this strain exhibits a homologous protein to V. cholerae PotD1 (Figure 
4). This demonstrates that PotD in this species may be performing a similar role in binding 
multiple polyamines that are needed for proper cell function. The ancestral evolutionary 
presence of periplasmic binding proteins, like PotD1, demonstrates the potential of these 
proteins to perform specific yet varied cellular duties.  
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